DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trovan (Trovafloxacin Mesylate) - Published Studies

 
 



Trovan Related Published Studies

Well-designed clinical trials possibly related to Trovan (Trovafloxacin)

Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics. [2008.04]

Other research related to Trovan (Trovafloxacin)

Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction. [2010.10.06]

Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosis. [2010.07]

Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection. [2010.07]

Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury. [2009.01]

Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. [2007.11]

Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin. [2005.01]

Other possibly related research studies

In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent. [2006.09]

Dog colonoscopy model for predicting human colon absorption. [2006.07]

In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia. [2005.01]

Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia. [2006.01]

Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia. [2006.04]

Telithromycin: The first ketolide antimicrobial. [2005.08]

Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice. [2005.09]

Antimicrobial safety: focus on fluoroquinolones. [2005.07.15]

Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia. [2005.02]

Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi. [2007.10]

Ocular toxicity of fluoroquinolones. [2007.08]

Knowledge creation about ADRs--turning the perspective from the rear mirror to the projector? [2008.03]

Topoisomerase II inhibition involves characteristic chromosomal expression patterns. [2008.07.08]

Sitafloxacin hydrate for bacterial infections. [2008.07]

Levofloxacin-induced delirium with psychotic features. [2008.07]

Understanding informed consent for participation in international health research. [2009.08]

Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. [2009]

Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. [2009.06.15]

Net efficacy adjusted for risk (NEAR): a simple procedure for measuring risk:benefit balance. [2008]

Clinical ethics in African countries and emerging nurse's role in Nigeria. [2009.12]

Ethical problems in conducting research in acute epidemics: the Pfizer meningitis study in Nigeria as an illustration. [2010.04]

The use of gastrointestinal intubation studies for controlled release development. [2009.09]

Hepatic safety of antibiotics used in primary care. [2011.07]

Clinical efficacy of moxifloxacin versus comparator therapies for community-acquired pneumonia caused by Legionella spp. [2010.08]

Ethical problems in conducting research in acute epidemics: the Pfizer meningitis study in Nigeria as an illustration. [2010]

Clinical efficacy of moxifloxacin versus comparator therapies for community-acquired pneumonia caused by Legionella spp. [2010]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017